|
|
|
|
|
Cancer Newsletter
|
|
Bring Your Biomarkers to Life with Steadfast Assay Consistency
|
|
Our MILLIPLEX® map assays using the Luminex® technology, Singulex Erenna® assays, ELISAs, and GyroMark™ HT assays provide:
• Standards validated to match reference lots
• In-assay controls
• Detection antibody cocktails
Learn about our technologies and validation criteria and sign up to receive our new poster!
read more
|
|
|
|
Research News
|
Higher levels of vitamin D correspond to lower cancer risk. read more
New insight into how key DNA sequences govern gene activity. read more
How a Metabolic Pathway Promotes Breast Cancer Metastasis. read more
Study suggests epiregulin as a target in lung cancer. read more
Researchers discover that breast cancer tumor growth is dependent on lipid availability. read more
New predictive tool for assessing breast cancer risk. read more
Engineers develop a pill for long-term drug release. read more
|
|
|
|
|
|
|
|
|
|
Serologically Defined Colon Cancer Antigen 3 (SDCCAG3) Antibody. read more
Tissue, Genomic DNA, Human Tumor, Breast Tumor, BioGenomics. read more
|
|
|
|
|
|
|
Event
|
|
AACR Annual Meeting 2016
|
|
The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. We are in a new era of great progress and promise in cancer research, and the AACR is pleased to provide a comprehensive program for learning, collaborating, and sharing extraordinary ... read more
|
|
|
analytica 2016
|
|
Join us from May 10-13, 2016 when the world's leading manufacturers in the analysis, laboratory technology and biotechnology industry gather in Munich, Germany. Leading international manufacturers will give you a concentrated and comprehensive look at the latest products and equipment for commercial... read more
|
|
|
More Events »
|
|
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA
|
|
You received this email because you are subscribed
to our database. Need to change your settings?
Email Settings or
Unsubscribe
|
|
